Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |